Shares of Clearmind Medicine Inc. (NASDAQ:CMND – Get Free Report) dropped 12.3% during trading on Monday . The stock traded as low as $1.53 and last traded at $1.54. Approximately 565,897 shares traded hands during mid-day trading, a decline of 62% from the average daily volume of 1,472,889 shares. The stock had previously closed at $1.76.
Clearmind Medicine Price Performance
The firm has a 50-day moving average of $1.31 and a 200 day moving average of $1.33. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.71 and a quick ratio of 1.71.
Clearmind Medicine (NASDAQ:CMND – Get Free Report) last issued its earnings results on Monday, September 16th. The company reported ($0.59) EPS for the quarter.
Institutional Inflows and Outflows
About Clearmind Medicine
Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.
Featured Articles
- Five stocks we like better than Clearmind Medicine
- What is a support level?
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How to Invest in the FAANG Stocks
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Clearmind Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearmind Medicine and related companies with MarketBeat.com's FREE daily email newsletter.